Home » Topics » BioWorld Science

BioWorld Science
RSS

Praxis Precision Medicines patents voltage-gated sodium channel blockers

Dec. 30, 2019

UBA1 as a potent and druggable target in TNBC

Dec. 30, 2019

Janssen presents results from phase II trials of JNJ-42165279

Dec. 30, 2019

Transplantation with MGTA-456 results in complete engraftment and rapid recovery

Dec. 30, 2019

Results for dose-optimization phase of PRIMO trial of duvelisib in patients with R/R PTCL

Dec. 30, 2019

New BALB/c-hCD3E mouse model for evaluating the therapeutic efficacy of T-cell bispecific Abs

Dec. 30, 2019

Interim phase II data presented for tazemetostat patients with follicular lymphoma

Dec. 30, 2019

Clinical hold on PR-001 study in neuronopathic Gaucher's disease removed

Dec. 27, 2019

Baergic Bio enters agreements with AstraZeneca and Cincinnati Children's Hospital for AZD-7325

Dec. 27, 2019

Roche and Genentech patent describes YAP1/TEAD interaction inhibitors

Dec. 27, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...